BME vs LSVD
BlackRock Health Sciences Trust vs LSV Disciplined Value ETF
Which is better, BME or LSVD?
LSVD has been ahead.
LSVD has a lower expense ratio. LSVD led over 1Y and the full window. LSVD is less concentrated, with 35.0% of the fund in its ten largest positions against 51.5%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BME | LSVD |
|---|---|---|
| Expense Ratio | 1.14% | 0.40%Best |
| AUM | $591M | $678M |
| Dividend Yield | 6.87% | 0.27% |
| Holdings | 156 | 136 |
| YTD Return | +13.85% | +20.92%Best |
| 1Y Return | +26.79% | +30.07%Best |
| 3Y Return (annualized) | +12.27% | - |
| 5Y Return (annualized) | +5.83% | - |
| Volatility (annualized) | 14.9% | 13.3%Best |
| Max Drawdown | -13.8%Best | -19.3% |
| $10,000 over 1.8 years | $13,528 | $14,810Best |
| Top 10 Weight | 51.5% | 35.0%Best |
| Fund Family | BlackRock, Inc. (US) | LSV Asset Management |
| Category | Equity | Equity |
| Style | Large Cap Value | Large Cap Value |
| Inception | Mar 31, 2005 | Dec 17, 2024 |
Volatility and max drawdown, and the $10,000 over 1.8 years row, are measured over the window both funds cover: Dec 18, 2024 to Oct 14, 2026 (1.8 years).
BME vs LSVD growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 1.8 years both funds cover.
BME vs LSVD Performance
BlackRock Health Sciences Trust (BME) is an ETF from BlackRock, Inc. (US) and LSV Disciplined Value ETF (LSVD) is an ETF from LSV Asset Management. Over the past year BME returned +26.79% while LSVD returned +30.07%. Year to date, BME is up 13.85% versus a gain of 20.92% for LSVD.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BME has been the more volatile fund, with annualized monthly volatility of 14.9% compared with 13.3% for LSVD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -13.8% for BME and -19.3% for LSVD. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.40. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BME charges 1.14% per year while LSVD charges 0.40%. On a $10,000 position that is $114 vs $40 annually, a gap of $74 per year that compounds over a long holding period. On income, BME currently yields 6.87% against 0.27% for LSVD.
Holdings Overlap
31.1% of BME's money is in holdings LSVD also owns. 8.9% of LSVD's money is in holdings BME also owns.
The two portfolios partly overlap.
The two holdings books were reported 93 days apart, BME as of Jun 30, 2026 and LSVD as of Oct 1, 2026, so some of the difference between them is the time between the two reports rather than the funds.
14 positions in common, counted across the 133 positions we hold weights for in BME and 135 in LSVD, against full books of 156 and 136.
What only one of them owns
Our book lists 119 positions for LSVD that do not appear in our book for BME (90.7% of the fund), and 100 for BME that do not appear in LSVD (58.8%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in BME | Weight in LSVD | Difference |
|---|---|---|---|
| JNJJohnson & Johnson - Common | 7.80% | 0.69% | 7.11% |
| UNHUnitedhealth Group Incorporated | 6.12% | 0.66% | 5.46% |
| MRKMerck & Company Inc | 5.23% | 1.12% | 4.11% |
| AMGNAmgen Inc. | 3.37% | 0.56% | 2.81% |
| PFEPfizer Inc | 1.49% | 0.84% | 0.65% |
| ELVElevance Health Inc | 1.86% | 0.42% | 1.44% |
| BIIBBiogen Inc. Com | 1.20% | 0.51% | 0.69% |
| BMYBristol-Myers Squibb Co. | 0.82% | 0.71% | 0.11% |
| REGNRegeneron Pharmaceuticals, Inc. | 0.84% | 0.57% | 0.27% |
| INCYIncyte Corporation Ltd. | 0.69% | 0.58% | 0.11% |
31.1% of BME is already inside LSVD.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BME or LSVD?
BME has an expense ratio of 1.14% while LSVD charges 0.40%. LSVD is the cheaper option, by $74 a year on a $10,000 investment.
Which performed better, BME or LSVD?
Over the past year BME returned +26.79% vs +30.07% for LSVD, so LSVD leads on 1-year performance. Over the longest common window we track (2 years), BME annualized +18.28% vs +24.38% for LSVD. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BME or LSVD?
BME has been the more volatile fund at 14.9% annualized versus 13.3% for LSVD. Worst drawdown: BME -13.8% vs LSVD -19.3%.
Should I hold both BME and LSVD?
BME and LSVD have a monthly-return correlation of 0.40, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BME and LSVD?
31.1% of BME's money is in holdings LSVD also owns. 8.9% of LSVD's is in holdings BME also owns. They hold 14 positions in common, counted across the 133 positions we hold weights for in BME and 135 in LSVD.
Which pays a higher dividend, BME or LSVD?
BME yields 6.87% while LSVD yields 0.27%, so BME currently pays the higher dividend yield.
Is LSVD better than BME?
LSVD has a lower expense ratio. LSVD led over 1Y and the full window. LSVD is less concentrated, with 35.0% of the fund in its ten largest positions against 51.5%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.